ABBV logo

AbbVie (ABBV) Revenue

Annual Revenue

$56.33 B
+$2.02 B+3.71%

December 1, 2024


Summary


Performance

ABBV Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABBVprofitabilitymetrics:

Quarterly Revenue

$15.10 B
+$642.00 M+4.44%

December 1, 2024


Summary


Performance

ABBV Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM Revenue

$56.33 B
+$801.00 M+1.44%

December 1, 2024


Summary


Performance

ABBV TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABBVprofitabilitymetrics:

ABBV Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.7%+4.4%+1.4%
3 y3 years+0.2%+3.6%-1.8%
5 y5 years+69.3%+73.5%+69.3%

ABBV Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3.0%+3.7%-0.1%+23.5%-3.0%+3.7%
5 y5-year-3.0%+69.3%-0.1%+75.2%-3.0%+69.3%
alltimeall time-3.0%+296.3%-0.1%+287.6%-3.0%+1345.7%

AbbVie Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$56.33 B(+3.7%)
$15.10 B(+4.4%)
$56.33 B(+1.4%)
Sep 2024
-
$14.46 B(-0.0%)
$55.53 B(+1.0%)
Jun 2024
-
$14.46 B(+17.5%)
$55.00 B(+1.1%)
Mar 2024
-
$12.31 B(-13.9%)
$54.40 B(+0.2%)
Dec 2023
$54.32 B(-6.4%)
$14.30 B(+2.7%)
$54.32 B(-1.5%)
Sep 2023
-
$13.93 B(+0.4%)
$55.14 B(-1.6%)
Jun 2023
-
$13.87 B(+13.4%)
$56.02 B(-1.3%)
Mar 2023
-
$12.22 B(-19.2%)
$56.74 B(-2.3%)
Dec 2022
$58.05 B(+3.3%)
$15.12 B(+2.1%)
$58.05 B(+0.4%)
Sep 2022
-
$14.81 B(+1.6%)
$57.82 B(+0.8%)
Jun 2022
-
$14.58 B(+7.7%)
$57.35 B(+1.1%)
Mar 2022
-
$13.54 B(-9.1%)
$56.73 B(+0.9%)
Dec 2021
$56.20 B(+22.7%)
$14.89 B(+3.8%)
$56.20 B(+1.9%)
Sep 2021
-
$14.34 B(+2.7%)
$55.17 B(+2.7%)
Jun 2021
-
$13.96 B(+7.3%)
$53.73 B(+7.0%)
Mar 2021
-
$13.01 B(-6.1%)
$50.20 B(+9.6%)
Dec 2020
$45.80 B(+37.7%)
$13.86 B(+7.4%)
$45.80 B(+12.7%)
Sep 2020
-
$12.90 B(+23.8%)
$40.65 B(+12.2%)
Jun 2020
-
$10.43 B(+21.0%)
$36.23 B(+6.4%)
Mar 2020
-
$8.62 B(-1.0%)
$34.06 B(+2.4%)
Dec 2019
$33.27 B(+1.6%)
$8.70 B(+2.7%)
$33.27 B(+1.2%)
Sep 2019
-
$8.48 B(+2.7%)
$32.87 B(+0.7%)
Jun 2019
-
$8.26 B(+5.5%)
$32.62 B(-0.1%)
Mar 2019
-
$7.83 B(-5.7%)
$32.65 B(-0.3%)
Dec 2018
$32.75 B(+16.1%)
$8.30 B(+0.8%)
$32.75 B(+1.8%)
Sep 2018
-
$8.24 B(-0.5%)
$32.19 B(+4.0%)
Jun 2018
-
$8.28 B(+4.3%)
$30.95 B(+4.5%)
Mar 2018
-
$7.93 B(+2.5%)
$29.61 B(+4.9%)
Dec 2017
$28.22 B
$7.74 B(+10.6%)
$28.22 B(+3.5%)
DateAnnualQuarterlyTTM
Sep 2017
-
$7.00 B(+0.7%)
$27.27 B(+2.1%)
Jun 2017
-
$6.94 B(+6.2%)
$26.71 B(+1.9%)
Mar 2017
-
$6.54 B(-3.8%)
$26.22 B(+2.3%)
Dec 2016
$25.64 B(+12.2%)
$6.80 B(+5.7%)
$25.64 B(+1.6%)
Sep 2016
-
$6.43 B(-0.3%)
$25.24 B(+2.0%)
Jun 2016
-
$6.45 B(+8.3%)
$24.75 B(+4.1%)
Mar 2016
-
$5.96 B(-6.9%)
$23.78 B(+4.0%)
Dec 2015
$22.86 B(+14.5%)
$6.40 B(+7.7%)
$22.86 B(+4.3%)
Sep 2015
-
$5.94 B(+8.6%)
$21.91 B(+4.4%)
Jun 2015
-
$5.47 B(+8.6%)
$20.99 B(+2.7%)
Mar 2015
-
$5.04 B(-7.6%)
$20.44 B(+2.4%)
Dec 2014
$19.96 B(+6.2%)
$5.45 B(+8.6%)
$19.96 B(+1.7%)
Sep 2014
-
$5.02 B(+1.9%)
$19.62 B(+1.9%)
Jun 2014
-
$4.93 B(+8.0%)
$19.26 B(+1.2%)
Mar 2014
-
$4.56 B(-10.7%)
$19.02 B(+1.2%)
Dec 2013
$18.79 B(+2.2%)
$5.11 B(+9.7%)
$18.79 B(-0.5%)
Sep 2013
-
$4.66 B(-0.7%)
$18.89 B(+0.8%)
Jun 2013
-
$4.69 B(+8.4%)
$18.73 B(+1.1%)
Mar 2013
-
$4.33 B(-16.8%)
$18.54 B(+0.8%)
Dec 2012
$18.38 B(+5.4%)
$5.21 B(+15.5%)
$18.38 B(+1.9%)
Sep 2012
-
$4.51 B(+0.3%)
$18.04 B(+0.6%)
Jun 2012
-
$4.49 B(+7.7%)
$17.94 B(+1.2%)
Mar 2012
-
$4.17 B(-14.2%)
$17.72 B(+1.6%)
Dec 2011
$17.44 B(+11.5%)
$4.86 B(+10.3%)
$17.44 B(+38.7%)
Sep 2011
-
$4.41 B(+3.1%)
$12.58 B(+54.0%)
Jun 2011
-
$4.27 B(+9.7%)
$8.17 B(+109.7%)
Mar 2011
-
$3.90 B
$3.90 B
Dec 2010
$15.64 B(+10.0%)
-
-
Dec 2009
$14.21 B
-
-

FAQ

  • What is AbbVie annual revenue?
  • What is the all time high annual revenue for AbbVie?
  • What is AbbVie annual revenue year-on-year change?
  • What is AbbVie quarterly revenue?
  • What is the all time high quarterly revenue for AbbVie?
  • What is AbbVie quarterly revenue year-on-year change?
  • What is AbbVie TTM revenue?
  • What is the all time high TTM revenue for AbbVie?
  • What is AbbVie TTM revenue year-on-year change?

What is AbbVie annual revenue?

The current annual revenue of ABBV is $56.33 B

What is the all time high annual revenue for AbbVie?

AbbVie all-time high annual revenue is $58.05 B

What is AbbVie annual revenue year-on-year change?

Over the past year, ABBV annual revenue has changed by +$2.02 B (+3.71%)

What is AbbVie quarterly revenue?

The current quarterly revenue of ABBV is $15.10 B

What is the all time high quarterly revenue for AbbVie?

AbbVie all-time high quarterly revenue is $15.12 B

What is AbbVie quarterly revenue year-on-year change?

Over the past year, ABBV quarterly revenue has changed by +$642.00 M (+4.44%)

What is AbbVie TTM revenue?

The current TTM revenue of ABBV is $56.33 B

What is the all time high TTM revenue for AbbVie?

AbbVie all-time high TTM revenue is $58.05 B

What is AbbVie TTM revenue year-on-year change?

Over the past year, ABBV TTM revenue has changed by +$801.00 M (+1.44%)